Bausch Health Companies Inc logo

Bausch Health Companies Inc

1
1
NYSE:BHC (Canada)  
$ 9.38 +0.18 (+1.96%) 11:08 PM EST
At Loss
Enterprise V:
$ 24.80B
Volume:
1.17M
Avg Vol (2M):
2.28M
Also Trade In:
Volume:
1.17M
At Loss
Avg Vol (2M):
2.28M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Bausch Health Companies Inc ( ) from 1994 to Mar 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bausch Healthmpanies stock (BHC) PE ratio as of Mar 19 2024 is 0. More Details

Bausch Health Companies Inc (BHC) PE Ratio (TTM) Chart

To

Bausch Health Companies Inc (BHC) PE Ratio (TTM) Historical Data

Total 1256
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Bausch Healthmpanies PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-03-19 At Loss 2024-01-16 At Loss
2024-03-18 At Loss 2024-01-15 At Loss
2024-03-15 At Loss 2024-01-12 At Loss
2024-03-14 At Loss 2024-01-11 At Loss
2024-03-13 At Loss 2024-01-10 At Loss
2024-03-12 At Loss 2024-01-09 At Loss
2024-03-11 At Loss 2024-01-08 At Loss
2024-03-08 At Loss 2024-01-05 At Loss
2024-03-07 At Loss 2024-01-04 At Loss
2024-03-06 At Loss 2024-01-03 At Loss
2024-03-05 At Loss 2024-01-02 At Loss
2024-03-04 At Loss 2024-01-01 At Loss
2024-03-01 At Loss 2023-12-29 At Loss
2024-02-29 At Loss 2023-12-28 At Loss
2024-02-28 At Loss 2023-12-27 At Loss
2024-02-27 At Loss 2023-12-26 At Loss
2024-02-26 At Loss 2023-12-22 At Loss
2024-02-23 At Loss 2023-12-21 At Loss
2024-02-22 At Loss 2023-12-20 At Loss
2024-02-21 At Loss 2023-12-19 At Loss
2024-02-20 At Loss 2023-12-18 At Loss
2024-02-19 At Loss 2023-12-15 At Loss
2024-02-16 At Loss 2023-12-14 At Loss
2024-02-15 At Loss 2023-12-13 At Loss
2024-02-14 At Loss 2023-12-12 At Loss
2024-02-13 At Loss 2023-12-11 At Loss
2024-02-12 At Loss 2023-12-08 At Loss
2024-02-09 At Loss 2023-12-07 At Loss
2024-02-08 At Loss 2023-12-06 At Loss
2024-02-07 At Loss 2023-12-05 At Loss
2024-02-06 At Loss 2023-12-04 At Loss
2024-02-05 At Loss 2023-12-01 At Loss
2024-02-02 At Loss 2023-11-30 At Loss
2024-02-01 At Loss 2023-11-29 At Loss
2024-01-31 At Loss 2023-11-28 At Loss
2024-01-30 At Loss 2023-11-27 At Loss
2024-01-29 At Loss 2023-11-24 At Loss
2024-01-26 At Loss 2023-11-22 At Loss
2024-01-25 At Loss 2023-11-21 At Loss
2024-01-24 At Loss 2023-11-20 At Loss
2024-01-23 At Loss 2023-11-17 At Loss
2024-01-22 At Loss 2023-11-16 At Loss
2024-01-19 At Loss 2023-11-15 At Loss
2024-01-18 At Loss 2023-11-14 At Loss
2024-01-17 At Loss 2023-11-13 At Loss

Bausch Health Companies Inc (BHC) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.